A PHP Error was encountered

Severity: Warning

Message: fopen(/var/www/meetingsint/application/ci_session/ci_sessionabcc7869d7e6a1dac149dc083cb8be64fbd1c2667022d21a810cbc3fdf380fe6a6a98b2e): failed to open stream: No space left on device

Filename: drivers/Session_files_driver.php

Line Number: 157

Backtrace:

File: /var/www/meetingsint/application/controllers/Conference.php
Line: 10
Function: __construct

File: /var/www/meetingsint/index.php
Line: 317
Function: require_once

Diabetes Conferences 2018 | Endocrinology Meetings | Diabetes Research Symposiums

4th International Conference on

Diabetes & Its Treatment

Dubai, UAE   November 26-27, 2018

Theme: Advanced Technologies and Innovations to Beat Diabetes

Meetings International enchanted to welcome you to the prestigious “4th International Conference on Diabetes & Its Treatment" held on November 26-27, 2018 at Dubai, UAE. This gathering will concentrate on the topic “Advanced Technologies and Innovations to Beat Diabetes ". We are sure that you will appreciate the Scientific Program of this up and coming Diabetes Conference.

Meetings International (Meetings Int.) is a global leader in producing high-quality diabetes conferences, diabetes meetings, diabetes workshops and diabetes symposia in all major fields of science, technology and medicine. Since its inception, Meetings Int. has been associated with national and international associations, corporations and high-level individuals, dedicated to host world-class conferences and events. Meetings Int. supports broad scope research and peer review at a broad range of specialists around the world. The key strategic objective of Meetings Int. is to communicate science and medical research between academia, and industry. Through inspiring sessions and tons of networking, you will learn to be even more audacious and bold than you are now and free to grow your mind, grow your business, and grow your bottom-line. We can relieve you of the time and resource draining elements of the events that you plan to hold. From planning to coordinating, start to finish; we will be there to ensure you take the accolades for yet another brilliant program. We organize conferences world-wide. All major conferences of Meetings International are accredited with Continuing Professional Development (CPD), Continuing Education (CE), and Continuing Medical Education (CME) Credits.

Diabetes mellitus is a group of metabolic diseases i.e. both catabolism and anabolism in which a person experiences high rate blood glucose levels either because the body produces inadequate insulin or the body cells do not respond properly to the insulin produced by the body. Patients with diabetes often experience frequent urination (polyuria), increased thirst (polydipsia) and increased hunger (polyphagia).There are three major forms of diabetes namely Type1, Type 2 and third form is known as gestational diabetes.Type1 and Type 2 were formerly known as insulin dependent and insulin non-dependent diabetes. The patients who are having Type1 diabetes their body fails to produce insulin and thus an insulin pump is required to inject it. Whereas in Type 2 diabetes, the cells are not able to use the insulin properly because of insulin resistance. Third form of diabetes is occurred when a pregnant woman develops a higher blood sugar level without having any previous history of diabetes.

Scope and Importance:

Diabetes is one of the rising ailments, which is ending up extremely normal these days. Diabetes is a metabolic illness in which the individual has high blood glucose (sugar), either on the grounds that insulin creation is lacking, or in light of the fact that the body's cells don't react legitimately to insulin or both. Patients with high glucose will encounter polyuria (visit pee), polydipsia and polyphagia. With the Change in way of life, our endocrine arrangement of the body is getting exasperates. Human services is vital as Diseases like Diabetes, which is a metabolic disorder is getting expands step by step. The investigations are more associated with the themes like Current Advances in Endocrinology and Metabolism; Chemistry, physiology, and clutters identified with Hypothalamus-Pituitary Axis, Thyroid and parathyroid organs and its Disorders, Reproductive Endocrinology, Diabetic Disorders and Treatment, Energy Balance and Obesity, Treatment and Diagnosis of Endocrine Diseases, Surgery, instrument of activity of peptide hormones and receptors and steroid hormones and receptors, Glycoprotein hormones (LSH, FSH, TH, hCG, POMC), Growth hormone family (GH, hCS, Prolactin), Adrenal Hormones and Endocrine direction. The Talk includes the real region to be Covered so that at a brief span, we can examine and discover the way and make another revelation in the field of Diabetes and Endocrinology.

 

Diabetes 2018 Meeting Highlights are listed below: 

 

Target Audience:

  • Doctors

  • Scientists

  • Research Scholar

  • Nutraceutical industry

  • Healthcare companies

  • Entrepreneurs

  • R&D Institutes

  • Healthcare Innovators

  • Public Health Professionals

  • Clinical Researchers

  • Life Science Investors

  •  Medical professors

  • Druggists

  • Diabetes Societies and Associations

  • Academic Researchers

 

Why to attend?

4th International Conference on Diabetes & Its Treatment which is going to be largest platform where you can exchange your ideas and learn novel concepts related to your field from the international speakers as well as the professionals participating in this symposium. We want to take every individual related to this field either to learn or share your experience in this field and improve your connections from the entire globe.

It’s important to share knowledge with others due to the newly generated problem. For that, they need a platform to share their knowledge. We could say we create a golden opportunity for those people to expose their knowledge through this conference. This conference helps to distribute new information, meet with current and potential customers, give a touch to a new product line, and receive name recognition at this 2-days event. World-renowned speakers, the most recent techniques and the advanced updates in the environment are hallmarks of this conference.

For more details, please visit: https://www.meetingsint.com/conferences/diabetes-research

Session 1: Recent Advancement in Diabetes

Biotechnological propels in diabetic medications have been expanding throughout the years. A few advances make finger-picking for blood a relic of days gone by, while others, for example, shut circle frameworks help mechanize insulin conveyance. With more of these gadgets being presented, treating diabetes is winding up significantly less demanding and more secure. The closed-loop system (CLS) also known as an artificial pancreas, helps makes type 1 diabetes more manageable by having a direct communication between the CGM and an insulin pump. The “open-loop” is replaced by the new technology concept that requires patients to access information from the CGM to determine how much insulin they need to inject themselves.

The FreeStyle Libre Constant Glucose Monitoring (CGM) framework requires no patient adjustment, neither by fingerstick or manual information section. It can supplant customary blood glucose observing. You wear a sensor on the back of the upper arm, which can be left as it is up for to 10 days, and use a reader to get the levels. There's no transmitter, as other CGM frameworks incorporate. You can spot patterns and audit eight long stretches of glucose level history.

Related conferences and Associations: American Diabetes Association's Scientific Sessions, June 22-26, 2018, Orlando, US, World Congress on Prevention of Diabetes and its Complications, July 15-18, 2018, Edinburgh, UK, Diabetes Complications Conference & Grand Rounds (DCOM 2018), July 24-25, 2018, Sarawak, Malaysia, World Congress on Diabetes and Endocrinology, August 22-23, 2018, Rome, Italy, Diabetic Foot Global Conference, October 11-13, 2018, Texas , US,  Immunology of Diabetes Society Congress, October 25-29, 2018, London, UK,  US National Conference on Prevention of Diabetes, November 16-18, 2018, Atlanta, US,  International Diabetes Federation Western Pacific Region Congress, November 22-25, 2018,  World Congress on Clinical Trials in Diabetes, December 3-4, 2018, Vienna, Austria. European Association for the Study of Diabetes, Italy, International Diabetes Federation, Belgium, Joslin Diabetes Center, US, Diabetes UK, London, Diabetes Hands Foundation, California, US, American Diabetes Association, Virginia, US, Insulin for Life USA, Florida, US.

 

Session 2: Diabetes and Nutrition

Medical nourishment treatment is a fundamental part of diabetes administration and of diabetes self-administration training. Also, in clinical practice, nourishment suggestions that have practically no supporting confirmation have been are as yet being given to people with diabetes. Appropriately, this position articulation gives confirm based standards and suggestions for diabetes medicinal nourishment treatment. The justification for this position proclamation is examined in the American Diabetes Association specialized technical review "Proof Based Nutrition Principles and Recommendations for the Treatment and Prevention of Diabetes and Related Complications," which talks about in detail the distributed research for every rule and suggestion.

Related conferences and Associations: American Diabetes Association's Scientific Sessions, June 22-26, 2018, Orlando, US, World Congress on Prevention of Diabetes and its Complications, July 15-18, 2018, Edinburgh, UK, Diabetes Complications Conference & Grand Rounds (DCOM 2018), July 24-25, 2018, Sarawak, Malaysia, World Congress on Diabetes and Endocrinology, August 22-23, 2018, Rome, Italy, Diabetic Foot Global Conference, October 11-13, 2018, Texas , US,  Immunology of Diabetes Society Congress, October 25-29, 2018, London, UK,  US National Conference on Prevention of Diabetes, November 16-18, 2018, Atlanta, US,  International Diabetes Federation Western Pacific Region Congress, November 22-25, 2018,  World Congress on Clinical Trials in Diabetes, December 3-4, 2018, Vienna, Austria. European Association for the Study of Diabetes, Italy, International Diabetes Federation, Belgium, Joslin Diabetes Center, US, Diabetes UK, London, Diabetes Hands Foundation, California, US, American Diabetes Association, Virginia, US, Insulin for Life USA, Florida, US.

 

 Session 3: Diabetes and Cancer

Diabetes and tumor are normal infections with a huge effect on health worldwide. Epidemiologic confirmation recommends that individuals with diabetes are at fundamentally higher hazard for some types of tumor. Sort 2 diabetes and tumor share numerous hazard factors, yet potential biologic connections between the two maladies are not entirely comprehended. Cancer and diabetes are diagnosed within the same individual more frequently than would be expected by chance, even after adjusting for age. Both diseases are complex with multiple subtypes. In addition, prove from observational investigations proposes that a few medicines used to treat hyperglycemia are related with either expanded or lessened danger of malignancy. Against this background, the American Diabetes Association and the American Cancer Society assembled an accord improvement meeting in December 2009.

Related conferences and Associations: American Diabetes Association's Scientific Sessions, June 22-26, 2018, Orlando, US, World Congress on Prevention of Diabetes and its Complications, July 15-18, 2018, Edinburgh, UK, Diabetes Complications Conference & Grand Rounds (DCOM 2018), July 24-25, 2018, Sarawak, Malaysia, World Congress on Diabetes and Endocrinology, August 22-23, 2018, Rome, Italy, Diabetic Foot Global Conference, October 11-13, 2018, Texas , US,  Immunology of Diabetes Society Congress, October 25-29, 2018, London, UK,  US National Conference on Prevention of Diabetes, November 16-18, 2018, Atlanta, US,  International Diabetes Federation Western Pacific Region Congress, November 22-25, 2018,  World Congress on Clinical Trials in Diabetes, December 3-4, 2018, Vienna, Austria. European Association for the Study of Diabetes, Italy, International Diabetes Federation, Belgium, Joslin Diabetes Center, US, Diabetes UK, London, Diabetes Hands Foundation, California, US, American Diabetes Association, Virginia, US, Insulin for Life USA, Florida, US.

 

Session 4: Genetic Diabetes

Suppose a condition in which if you have type 1 diabetes, you might wonder if your child would get it, too. Or if by chance one of your parents has it, what it means for you.

There's no such diabetes quality that gets turned on or off to give you write 1. Rather, a pack of them assume a part, including twelve or so that have the greatest say: the HLA qualities. They make proteins your insusceptible framework uses to keep you solid. Since type 1 diabetes is an immune system ailment - your body devastates the cells that make insulin - it bodes well that HLA qualities are up front.

There are a huge number of forms of them in the human quality pool. Which ones you get from your folks influence your odds of diabetes. Some make you more inclined to get it, while others can help shield you from it. You have type 1 if your body makes practically no insulin, a hormone that enables your body to transform sugar into vitality.

Related conferences and Associations: American Diabetes Association's Scientific Sessions, June 22-26, 2018, Orlando, US, World Congress on Prevention of Diabetes and its Complications, July 15-18, 2018, Edinburgh, UK, Diabetes Complications Conference & Grand Rounds (DCOM 2018), July 24-25, 2018, Sarawak, Malaysia, World Congress on Diabetes and Endocrinology, August 22-23, 2018, Rome, Italy, Diabetic Foot Global Conference, October 11-13, 2018, Texas , US,  Immunology of Diabetes Society Congress, October 25-29, 2018, London, UK,  US National Conference on Prevention of Diabetes, November 16-18, 2018, Atlanta, US,  International Diabetes Federation Western Pacific Region Congress, November 22-25, 2018,  World Congress on Clinical Trials in Diabetes, December 3-4, 2018, Vienna, Austria. European Association for the Study of Diabetes, Italy, International Diabetes Federation, Belgium, Joslin Diabetes Center, US, Diabetes UK, London, Diabetes Hands Foundation, California, US, American Diabetes Association, Virginia, US, Insulin for Life USA, Florida, US.

 

Session 5: Biomarkers for Diabetes

Biomarkers are expectedly characterized as 'natural particles that speak to wellbeing and illness states.' They commonly are estimated in promptly accessible body liquids (blood or pee), lie outside the causal pathway, can distinguish sub-clinical malady, and are utilized to screen clinical and sub-clinical sickness weight and reaction to medications.

Diabetes mellitus is a perplexing infection influencing relatively every tissue and organ framework, with metabolic consequences reaching out a long ways past impeded glucose digestion. Biomarkers may mirror the nearness and seriousness of hyperglycemia (i.e. diabetes itself) or the nearness and seriousness of the vascular entanglements of diabetes. Illustrative cases are considered in this short survey. In blood, hemoglobin A1c (HbA1c) might be considered as a biomarker for the nearness and seriousness of hyperglycemia, inferring diabetes or pre-diabetes, or, after some time, as a "biomarker for a hazard factor", i.e. hyperglycemia as a hazard factor for diabetic retinopathy, nephropathy, and other vascular intricacies of diabetes. In tissues, glycation and oxidative pressure coming about because of hyperglycemia and dyslipidemia prompt boundless change of biomolecules by cutting edge glycation final results (AGEs).

Related conferences and Associations: American Diabetes Association's Scientific Sessions, June 22-26, 2018, Orlando, US, World Congress on Prevention of Diabetes and its Complications, July 15-18, 2018, Edinburgh, UK, Diabetes Complications Conference & Grand Rounds (DCOM 2018), July 24-25, 2018, Sarawak, Malaysia, World Congress on Diabetes and Endocrinology, August 22-23, 2018, Rome, Italy, Diabetic Foot Global Conference, October 11-13, 2018, Texas , US,  Immunology of Diabetes Society Congress, October 25-29, 2018, London, UK,  US National Conference on Prevention of Diabetes, November 16-18, 2018, Atlanta, US,  International Diabetes Federation Western Pacific Region Congress, November 22-25, 2018,  World Congress on Clinical Trials in Diabetes, December 3-4, 2018, Vienna, Austria. European Association for the Study of Diabetes, Italy, International Diabetes Federation, Belgium, Joslin Diabetes Center, US, Diabetes UK, London, Diabetes Hands Foundation, California, US, American Diabetes Association, Virginia, US, Insulin for Life USA, Florida, US.

 

Session 6: Diabetes and Obesity

The chances of developing the common type of diabetes i.e. type 2 diabetes are due to the person's overweight and obese condition. The body makes enough insulin is made by the body in this disease but the cells in the body have become resistant to the salutary action of insulin.

As indicated by the report related with Science suggests that being overweight anxieties the interior parts of individual cells. In particular, gorging stresses the membranous system within cells called endoplasmic reticulum (ER). At the point when the ER has a larger number of supplements to process than it can deal with, it conveys an alert flag advising the cell to hose down the insulin receptors on the cell surface. This means insulin obstruction and to perseveringly high groupings of the sugar glucose in the blood - one of the beyond any doubt indications of diabetes.

Related conferences and Associations: American Diabetes Association's Scientific Sessions, June 22-26, 2018, Orlando, US, World Congress on Prevention of Diabetes and its Complications, July 15-18, 2018, Edinburgh, UK, Diabetes Complications Conference & Grand Rounds (DCOM 2018), July 24-25, 2018, Sarawak, Malaysia, World Congress on Diabetes and Endocrinology, August 22-23, 2018, Rome, Italy, Diabetic Foot Global Conference, October 11-13, 2018, Texas , US,  Immunology of Diabetes Society Congress, October 25-29, 2018, London, UK,  US National Conference on Prevention of Diabetes, November 16-18, 2018, Atlanta, US,  International Diabetes Federation Western Pacific Region Congress, November 22-25, 2018,  World Congress on Clinical Trials in Diabetes, December 3-4, 2018, Vienna, Austria. European Association for the Study of Diabetes, Italy, International Diabetes Federation, Belgium, Joslin Diabetes Center, US, Diabetes UK, London, Diabetes Hands Foundation, California, US, American Diabetes Association, Virginia, US, Insulin for Life USA, Florida, US.

 

Session 7: Diabetic Meal Plan   

If you have diabetes, your body can't make or appropriately utilize insulin. This prompts high blood glucose, or glucose, levels. Adhering to a good diet helps keep your glucose in your objective range. It is a basic piece of dealing with your diabetes, on the grounds that controlling your glucose can keep the intricacies of diabetes.

Healthy diabetic eating incorporates: Limiting sustenances that are high in sugar , Eating littler parts, spread out finished the day, Being cautious about when and what number of starches you eat, Eating an assortment of entire grain nourishments, foods grown from the ground each day, Eating less fat, Limiting your utilization of liquor, Using less salt.

Related conferences and Associations: American Diabetes Association's Scientific Sessions, June 22-26, 2018, Orlando, US, World Congress on Prevention of Diabetes and its Complications, July 15-18, 2018, Edinburgh, UK, Diabetes Complications Conference & Grand Rounds (DCOM 2018), July 24-25, 2018, Sarawak, Malaysia, World Congress on Diabetes and Endocrinology, August 22-23, 2018, Rome, Italy, Diabetic Foot Global Conference, October 11-13, 2018, Texas , US,  Immunology of Diabetes Society Congress, October 25-29, 2018, London, UK,  US National Conference on Prevention of Diabetes, November 16-18, 2018, Atlanta, US,  International Diabetes Federation Western Pacific Region Congress, November 22-25, 2018,  World Congress on Clinical Trials in Diabetes, December 3-4, 2018, Vienna, Austria. European Association for the Study of Diabetes, Italy, International Diabetes Federation, Belgium, Joslin Diabetes Center, US, Diabetes UK, London, Diabetes Hands Foundation, California, US, American Diabetes Association, Virginia, US, Insulin for Life USA, Florida, US.

 

Session 8: Diabetes and Immunology

Type 1 diabetes is a ceaseless immune system sickness coming about because of the invulnerable decimation of insulin-delivering β-cells in pancreatic islets. It is presently a predicable malady in people with the estimation of islet autoantibodies. Regardless of the capacity to evaluate malady chance, there is no cure for type 1 diabetes and treatment requires deep-rooted insulin organization. People with type 1 diabetes are in danger of long-haul confusions of the malady and the improvement of an attendant immune system issue. Our comprehension of the immunology of diabetes has expanded extraordinarily finished the most recent decade at a fundamental science level, with interpretation to type 1 diabetes patients. Treatments are rising to forestall beta cell annihilation in these patients.

Related conferences and Associations: American Diabetes Association's Scientific Sessions, June 22-26, 2018, Orlando, US, World Congress on Prevention of Diabetes and its Complications, July 15-18, 2018, Edinburgh, UK, Diabetes Complications Conference & Grand Rounds (DCOM 2018), July 24-25, 2018, Sarawak, Malaysia, World Congress on Diabetes and Endocrinology, August 22-23, 2018, Rome, Italy, Diabetic Foot Global Conference, October 11-13, 2018, Texas , US,  Immunology of Diabetes Society Congress, October 25-29, 2018, London, UK,  US National Conference on Prevention of Diabetes, November 16-18, 2018, Atlanta, US,  International Diabetes Federation Western Pacific Region Congress, November 22-25, 2018,  World Congress on Clinical Trials in Diabetes, December 3-4, 2018, Vienna, Austria. European Association for the Study of Diabetes, Italy, International Diabetes Federation, Belgium, Joslin Diabetes Center, US, Diabetes UK, London, Diabetes Hands Foundation, California, US, American Diabetes Association, Virginia, US, Insulin for Life USA, Florida, US.

 

Session 9: Consequences of Diabetes in Human

The worldwide prevalence of diabetes mellitus among grown-ups has ascended from 4.7% out of 1980 to 8.5% of every 2014, expanding the number of diabetes mellitus in adults to a stunning 422 million around the world, as indicated by the World Health Organization. For correlation, this number is bigger than the aggregate populace of the United States. Diabetes mellitus not just diminishes personal satisfaction and future, but at the same time is a noteworthy reason for a few microvascular entanglements and macrovascular intricacies that prompt visual deficiency, renal disappointment, myocardial localized necrosis, stroke, and the need to excise appendages.

A substantial assortment of research has been given to distinguishing hazard elements of vascular entanglements of diabetes mellitus with the objective of enhancing the counteractive action of these inconveniences. Such research has revealed that vascular intricacies of diabetes mellitus are related to numerous hazard factors—including dyslipidemia, hypertension, smoking, age, metabolic control, and fundamental aggravation—and that the relative commitment of these hazard factors is probably going to fluctuate contingent upon the sort of diabetes mellitus and what chance elements are available in a given subject. Other research is gone for discovering novel and solid biomarkers for vascular complexities of diabetes mellitus and novel focuses for treatment.

Related conferences and Associations: American Diabetes Association's Scientific Sessions, June 22-26, 2018, Orlando, US, World Congress on Prevention of Diabetes and its Complications, July 15-18, 2018, Edinburgh, UK, Diabetes Complications Conference & Grand Rounds (DCOM 2018), July 24-25, 2018, Sarawak, Malaysia, World Congress on Diabetes and Endocrinology, August 22-23, 2018, Rome, Italy, Diabetic Foot Global Conference, October 11-13, 2018, Texas , US,  Immunology of Diabetes Society Congress, October 25-29, 2018, London, UK,  US National Conference on Prevention of Diabetes, November 16-18, 2018, Atlanta, US,  International Diabetes Federation Western Pacific Region Congress, November 22-25, 2018,  World Congress on Clinical Trials in Diabetes, December 3-4, 2018, Vienna, Austria. European Association for the Study of Diabetes, Italy, International Diabetes Federation, Belgium, Joslin Diabetes Center, US, Diabetes UK, London, Diabetes Hands Foundation, California, US, American Diabetes Association, Virginia, US, Insulin for Life USA, Florida, US.

 

Session 10: Stem Cell Therapy for Diabetes

For diabetes mellitus, the curative therapy mainly implies replacement of pancreatic β cells i.e. functional insulin-producing, with pancreas or islet-cell transplants. However, shortage of donor organs spurs research into alternative means of generating β cells from islet expansion, encapsulated islet xenografts, human islet cell-lines, and stem cells. Stem-cell therapy here implies the replacement of diseased or lost cells from the progeny of pluripotent or multipotent cells. Both embryonic stem cells (derived from the inner cell mass of a blastocyst) and adult stem cells (found in the postnatal organism) have been used to generate surrogate β cells or otherwise re-establish β-cell functioning.

The bone marrow transplant is the most widely used stem-cell therapy, but some therapies derived from umbilical cord blood are also in use. Research is underway to develop various sources for stem cells, as well as to apply stem-cell treatments for neurodegenerative diseases and conditions such as diabetes and heart disease, among others.

Stem-cell therapy has become controversial following developments such as the ability of scientists to isolate and culture embryonic stem cells, to create stem cells using somatic cell nuclear transfer and their use of techniques to create induced pluripotent stem cells. This controversy is often related to abortion politics and to human cloning. Additionally, efforts to market treatments based on the transplant of stored umbilical cord blood have been controversial.

Related conferences and Associations: American Diabetes Association's Scientific Sessions, June 22-26, 2018, Orlando, US, World Congress on Prevention of Diabetes and its Complications, July 15-18, 2018, Edinburgh, UK, Diabetes Complications Conference & Grand Rounds (DCOM 2018), July 24-25, 2018, Sarawak, Malaysia, World Congress on Diabetes and Endocrinology, August 22-23, 2018, Rome, Italy, Diabetic Foot Global Conference, October 11-13, 2018, Texas , US,  Immunology of Diabetes Society Congress, October 25-29, 2018, London, UK,  US National Conference on Prevention of Diabetes, November 16-18, 2018, Atlanta, US,  International Diabetes Federation Western Pacific Region Congress, November 22-25, 2018,  World Congress on Clinical Trials in Diabetes, December 3-4, 2018, Vienna, Austria. European Association for the Study of Diabetes, Italy, International Diabetes Federation, Belgium, Joslin Diabetes Center, US, Diabetes UK, London, Diabetes Hands Foundation, California, US, American Diabetes Association, Virginia, US, Insulin for Life USA, Florida, US.

 

Session 11: Cellular and Molecular Endocrinology

Molecular and Cellular Endocrinology was built up in 1974 to take care of the demand for coordinated distribution on all perspectives identified with the hereditary and biochemical impacts, union and emissions of extracellular signs (hormones, neurotransmitters, and so on.) and to the comprehension of cell administrative instruments engaged with hormonal control.

The Molecular and Cellular Endocrinology Research Section [MCE] surveys applications that address the sub-atomic and cell science of endocrine organs and their items, the two hormones and development factors. This includes the synthesis and secretion of local and circulating hormones and development variables, polypeptides and lipid-based ligands and their systems of activity with cell-surface and atomic receptors to impact cell structure, work, and the control of quality articulation in both typical and pathologic states. Molecular and cellular endocrinology of the cell and translational and clinical examinations are incorporated.

Related conferences and Associations: American Diabetes Association's Scientific Sessions, June 22-26, 2018, Orlando, US, World Congress on Prevention of Diabetes and its Complications, July 15-18, 2018, Edinburgh, UK, Diabetes Complications Conference & Grand Rounds (DCOM 2018), July 24-25, 2018, Sarawak, Malaysia, World Congress on Diabetes and Endocrinology, August 22-23, 2018, Rome, Italy, Diabetic Foot Global Conference, October 11-13, 2018, Texas , US,  Immunology of Diabetes Society Congress, October 25-29, 2018, London, UK,  US National Conference on Prevention of Diabetes, November 16-18, 2018, Atlanta, US,  International Diabetes Federation Western Pacific Region Congress, November 22-25, 2018,  World Congress on Clinical Trials in Diabetes, December 3-4, 2018, Vienna, Austria. European Association for the Study of Diabetes, Italy, International Diabetes Federation, Belgium, Joslin Diabetes Center, US, Diabetes UK, London, Diabetes Hands Foundation, California, US, American Diabetes Association, Virginia, US, Insulin for Life USA, Florida, US.

 

Session 12: Diabetes in Healthcare

Diabetes medicinal services experts strive to help their patients to comprehend the significance of good diabetes administration and to assist them in making the change in lifestyle that makes great administration possible. In any case, as diabetes experts are intensely aware, the capacity of individuals with diabetes to deal with their disease depends on a variety of societal factors. Adults with diabetes who face discrimination in the workplace are limited in their ability to provide economically for themselves and their families. Thus, it is useful to think of discrimination against people with diabetes both in terms of fairness issues and as a matter of facilitating good diabetes management. Any time a health care professional fills in a form for a school, employer, or licensing board, the form is used by individuals who then decide whether to treat a person with diabetes fairly.

Related conferences and Associations: American Diabetes Association's Scientific Sessions, June 22-26, 2018, Orlando, US, World Congress on Prevention of Diabetes and its Complications, July 15-18, 2018, Edinburgh, UK, Diabetes Complications Conference & Grand Rounds (DCOM 2018), July 24-25, 2018, Sarawak, Malaysia, World Congress on Diabetes and Endocrinology, August 22-23, 2018, Rome, Italy, Diabetic Foot Global Conference, October 11-13, 2018, Texas , US,  Immunology of Diabetes Society Congress, October 25-29, 2018, London, UK,  US National Conference on Prevention of Diabetes, November 16-18, 2018, Atlanta, US,  International Diabetes Federation Western Pacific Region Congress, November 22-25, 2018,  World Congress on Clinical Trials in Diabetes, December 3-4, 2018, Vienna, Austria. European Association for the Study of Diabetes, Italy, International Diabetes Federation, Belgium, Joslin Diabetes Center, US, Diabetes UK, London, Diabetes Hands Foundation, California, US, American Diabetes Association, Virginia, US, Insulin for Life USA, Florida, US.

 

Session 13: Case Studies and New Research Advances in Diabetes

Clinical case study aims to directly improve global health outcomes and share clinical knowledge using case reports to convey important best practice messages. If the case study is done then the advanced medical technologies like transplantation, holistic treatment can be used more rapidly in hospitals and with the more study in Glycemic index and load, we can find the diseases or problem like Cortisol. Even with this, we can know the number of people by using Diabetes Statistics having diseases and can find by advances in diabetes cure. Drug mechanism can be known and along with these new technologies as well pharmacotherapy can be done. A clinical case study done on medical diabetes could lead to finding an innovative way of treating diabetes. In this Diabetes and Healthcare Conference, Diabetes workshops and symposiums are also conducted.

Related conferences and Associations: American Diabetes Association's Scientific Sessions, June 22-26, 2018, Orlando, US, World Congress on Prevention of Diabetes and its Complications, July 15-18, 2018, Edinburgh, UK, Diabetes Complications Conference & Grand Rounds (DCOM 2018), July 24-25, 2018, Sarawak, Malaysia, World Congress on Diabetes and Endocrinology, August 22-23, 2018, Rome, Italy, Diabetic Foot Global Conference, October 11-13, 2018, Texas , US,  Immunology of Diabetes Society Congress, October 25-29, 2018, London, UK,  US National Conference on Prevention of Diabetes, November 16-18, 2018, Atlanta, US,  International Diabetes Federation Western Pacific Region Congress, November 22-25, 2018,  World Congress on Clinical Trials in Diabetes, December 3-4, 2018, Vienna, Austria. European Association for the Study of Diabetes, Italy, International Diabetes Federation, Belgium, Joslin Diabetes Center, US, Diabetes UK, London, Diabetes Hands Foundation, California, US, American Diabetes Association, Virginia, US, Insulin for Life USA, Florida, US.

 

Session 14: Diabetic Retinopathy

The Diabetic Eye Disease Awareness Month is in November, which aims to increase awareness of diabetes and diabetic eye disease and encourage people with diabetes to seek treatment for vision problems related to diabetes. Diabetic retinopathy is a condition that occurs in people who have diabetes. It causes progressive damage to the retina, the light-sensitive lining at the back of the eye. Diabetic retinopathy is a serious sight-threatening complication of diabetes. Diabetes interferes with the body's ability to use and store sugar (glucose). The disease is characterized by too much sugar in the blood, which can cause damage throughout the body, including the eyes. Diabetes damages the blood vessels in the retina. Diabetic retinopathy occurs when these tiny blood vessels leak blood and other fluids. This causes the retinal tissue to swell, resulting in cloudy or blurred vision. The condition usually affects both eyes. The longer a person has diabetes, the more likely they will develop diabetic retinopathy. If left untreated, diabetic retinopathy can cause blindness.

 Related conferences and Associations: American Diabetes Association's Scientific Sessions, June 22-26, 2018, Orlando, US, World Congress on Prevention of Diabetes and its Complications, July 15-18, 2018, Edinburgh, UK, Diabetes Complications Conference & Grand Rounds (DCOM 2018), July 24-25, 2018, Sarawak, Malaysia, World Congress on Diabetes and Endocrinology, August 22-23, 2018, Rome, Italy, Diabetic Foot Global Conference, October 11-13, 2018, Texas , US,  Immunology of Diabetes Society Congress, October 25-29, 2018, London, UK,  US National Conference on Prevention of Diabetes, November 16-18, 2018, Atlanta, US,  International Diabetes Federation Western Pacific Region Congress, November 22-25, 2018,  World Congress on Clinical Trials in Diabetes, December 3-4, 2018, Vienna, Austria. European Association for the Study of Diabetes, Italy, International Diabetes Federation, Belgium, Joslin Diabetes Center, US, Diabetes UK, London, Diabetes Hands Foundation, California, US, American Diabetes Association, Virginia, US, Insulin for Life USA, Florida, US.

 

Session 15: Diabetes and Treatment

Diabetes is a serious ailment that you can't treat without anyone else. Your specialist will enable you to influence a diabetes treatment to arrange for that is appropriate for you - and that you can get it. You may likewise require other human services experts on your diabetes treatment group, including a foot specialist, nutritionist, eye specialist, and a diabetes master (called an endocrinologist).

Treatment for diabetes requires keeping close watch over your glucose levels (and keeping them at an objective set by your specialist) with a blend of solutions, exercise, and eating routine. By giving careful consideration to what and when you eat, you can limit or stay away from the "see-saw effect" of quickly changing glucose levels, which can require fast changes in solution measurements, particularly insulin.

Related conferences and Associations: American Diabetes Association's Scientific Sessions, June 22-26, 2018, Orlando, US, World Congress on Prevention of Diabetes and its Complications, July 15-18, 2018, Edinburgh, UK, Diabetes Complications Conference & Grand Rounds (DCOM 2018), July 24-25, 2018, Sarawak, Malaysia, World Congress on Diabetes and Endocrinology, August 22-23, 2018, Rome, Italy, Diabetic Foot Global Conference, October 11-13, 2018, Texas , US,  Immunology of Diabetes Society Congress, October 25-29, 2018, London, UK,  US National Conference on Prevention of Diabetes, November 16-18, 2018, Atlanta, US,  International Diabetes Federation Western Pacific Region Congress, November 22-25, 2018,  World Congress on Clinical Trials in Diabetes, December 3-4, 2018, Vienna, Austria. European Association for the Study of Diabetes, Italy, International Diabetes Federation, Belgium, Joslin Diabetes Center, US, Diabetes UK, London, Diabetes Hands Foundation, California, US, American Diabetes Association, Virginia, US, Insulin for Life USA, Florida, US.

 

Session 16: Neurologic Problems and Diabetes

Neuropathy as a complication of diabetes is common and presents in a wide variety of clinical scenarios. Often the work-up is one of exclusion tempered with monitoring the response of symptoms to treatment options. The collaboration of a neurologist is often crucial to determining the best course of action for the patient.

A wide assortment of aggravations influencing the focal and fringe sensory systems, either straightforwardly or in a roundabout way, might be experienced in patients with diabetes mellitus. This gathering focuses on ongoing advancement in the outline of the clinical highlights of the neurological disorders identified with diabetes and their administration. It will bargain, successively, with the order of diabetes, a posting of some hereditary issue that might be joined by diabetes, certain contaminations that have a specific relationship with diabetes.

Related conferences and Associations: American Diabetes Association's Scientific Sessions, June 22-26, 2018, Orlando, US, World Congress on Prevention of Diabetes and its Complications, July 15-18, 2018, Edinburgh, UK, Diabetes Complications Conference & Grand Rounds (DCOM 2018), July 24-25, 2018, Sarawak, Malaysia, World Congress on Diabetes and Endocrinology, August 22-23, 2018, Rome, Italy, Diabetic Foot Global Conference, October 11-13, 2018, Texas , US,  Immunology of Diabetes Society Congress, October 25-29, 2018, London, UK,  US National Conference on Prevention of Diabetes, November 16-18, 2018, Atlanta, US,  International Diabetes Federation Western Pacific Region Congress, November 22-25, 2018,  World Congress on Clinical Trials in Diabetes, December 3-4, 2018, Vienna, Austria. European Association for the Study of Diabetes, Italy, International Diabetes Federation, Belgium, Joslin Diabetes Center, US, Diabetes UK, London, Diabetes Hands Foundation, California, US, American Diabetes Association, Virginia, US, Insulin for Life USA, Florida, US.

 

Session 17: Hypertension and Diabetes

Studies have discovered that no less than 1 of every 3 patients with type 1 diabetes likewise has hypertension. Whenever hypertension and diabetes exist together, the impacts of one malady tend to aggravate the other. This makes for a dangerous mix. Diabetes completes three things that may expand circulatory strain: diminishing the veins' capacity to extend, expanding the measure of liquid in the body, changing the way the body oversees insulin.

Hypertension and diabetes, for the most part, coincide on the grounds that they share comparable hazard factors, including being overweight, after an unfortunate eating regimen, and living an inert lifestyle. Patients should report any predictable circulatory strain readings of 140/90 or higher to their specialists, as these may bring about intricacies. The blend of hypertension and diabetes can be deadly, and together they can expand the danger of a heart assault or stroke. Having the two conditions additionally builds the danger of kidney malady and issues the veins of the eyes, which could prompt visual deficiency.

Related conferences and Associations: American Diabetes Association's Scientific Sessions, June 22-26, 2018, Orlando, US, World Congress on Prevention of Diabetes and its Complications, July 15-18, 2018, Edinburgh, UK, Diabetes Complications Conference & Grand Rounds (DCOM 2018), July 24-25, 2018, Sarawak, Malaysia, World Congress on Diabetes and Endocrinology, August 22-23, 2018, Rome, Italy, Diabetic Foot Global Conference, October 11-13, 2018, Texas , US,  Immunology of Diabetes Society Congress, October 25-29, 2018, London, UK,  US National Conference on Prevention of Diabetes, November 16-18, 2018, Atlanta, US,  International Diabetes Federation Western Pacific Region Congress, November 22-25, 2018,  World Congress on Clinical Trials in Diabetes, December 3-4, 2018, Vienna, Austria. European Association for the Study of Diabetes, Italy, International Diabetes Federation, Belgium, Joslin Diabetes Center, US, Diabetes UK, London, Diabetes Hands Foundation, California, US, American Diabetes Association, Virginia, US, Insulin for Life USA, Florida, US.

 

Session 18: Endocrine Complications of Diabetes

Diabetic perplexities radiate an impression of being multifactorial in starting, yet particularly, the biochemical system of forefront glycation, which is enlivened in diabetes as a result of perpetual hyperglycemia and extended oxidative weight, has been conjectured to accept a central part in the endocrine issue. The endocrine issue is frequently extremely unusual, including a mixed picture of hypo outflow and hyper release because of the feedback instruments connected with the endocrine system. Endocrinology centers for the most part around the endocrine organs or those organs that may understand hormone ungainliness. These organs combine the pituitary, thyroid, adrenals, ovaries, gonads, and pancreas. This can be a convoluted strength. There are different organs and hormones in the body, each with their own particular occupations to do. It is a fragile compound alter that keeps our bodies running adequately with nearby no exertion on our part. Patients with diabetes mellitus have an extended threat of working up some rheumatologic diseases, including muscle-restricted putrefaction, carpal entry disorder, and so on.

Related conferences and Associations: American Diabetes Association's Scientific Sessions, June 22-26, 2018, Orlando, US, World Congress on Prevention of Diabetes and its Complications, July 15-18, 2018, Edinburgh, UK, Diabetes Complications Conference & Grand Rounds (DCOM 2018), July 24-25, 2018, Sarawak, Malaysia, World Congress on Diabetes and Endocrinology, August 22-23, 2018, Rome, Italy, Diabetic Foot Global Conference, October 11-13, 2018, Texas , US,  Immunology of Diabetes Society Congress, October 25-29, 2018, London, UK,  US National Conference on Prevention of Diabetes, November 16-18, 2018, Atlanta, US,  International Diabetes Federation Western Pacific Region Congress, November 22-25, 2018,  World Congress on Clinical Trials in Diabetes, December 3-4, 2018, Vienna, Austria. European Association for the Study of Diabetes, Italy, International Diabetes Federation, Belgium, Joslin Diabetes Center, US, Diabetes UK, London, Diabetes Hands Foundation, California, US, American Diabetes Association, Virginia, US, Insulin for Life USA, Florida, US.

 

Session 19: Diabetes and Cardiovascular Diseases

Diabetes is treatable, however notwithstanding when glucose levels are under control it significantly builds the danger of coronary illness and stroke. That is on account of individuals with diabetes, especially type 2 diabetes, may have the accompanying conditions that add to their hazard for creating cardiovascular malady. Hypertension has for some time been perceived as a noteworthy hazard factor for cardiovascular illness. Studies report a positive relationship amongst hypertension and insulin obstruction. Patients with diabetes frequently have unfortunate cholesterol levels including high LDL ("terrible") cholesterol, low HDL ("great") cholesterol, and high triglycerides. Stoutness is a noteworthy hazard factor for cardiovascular sickness and has been firmly connected with insulin opposition. Weight reduction can enhance cardiovascular hazard, diminish insulin focus and increment insulin affectability. Diabetes can cause glucose to ascend to hazardous levels. Prescriptions might be expected to oversee glucose and so on.

Related conferences and Associations: American Diabetes Association's Scientific Sessions, June 22-26, 2018, Orlando, US, World Congress on Prevention of Diabetes and its Complications, July 15-18, 2018, Edinburgh, UK, Diabetes Complications Conference & Grand Rounds (DCOM 2018), July 24-25, 2018, Sarawak, Malaysia, World Congress on Diabetes and Endocrinology, August 22-23, 2018, Rome, Italy, Diabetic Foot Global Conference, October 11-13, 2018, Texas , US,  Immunology of Diabetes Society Congress, October 25-29, 2018, London, UK,  US National Conference on Prevention of Diabetes, November 16-18, 2018, Atlanta, US,  International Diabetes Federation Western Pacific Region Congress, November 22-25, 2018,  World Congress on Clinical Trials in Diabetes, December 3-4, 2018, Vienna, Austria. European Association for the Study of Diabetes, Italy, International Diabetes Federation, Belgium, Joslin Diabetes Center, US, Diabetes UK, London, Diabetes Hands Foundation, California, US, American Diabetes Association, Virginia, US, Insulin for Life USA, Florida, US.

 

Session 20:  Pediatric diabetes

Type 1 diabetes mellitus (T1D) and type 2 diabetes mellitus (T2D) are on the increase in children and adolescents. An increase in T2D is linked to the increasing rates of obesity in children. Usually, in both children and adults, T1D is treated with insulin while T2D is treated with metformin. There are other classes of drugs that are under assessment for their safety and efficacy in relation to pediatric patients. Most of these new drugs, however, have not been studied in children. Thus, the repertoire of drugs that are available to treat diabetes in children is limited. In this review, we outline the current pathology and treatment and future therapies of T1D mellitus and T2D mellitus in children.

Related conferences and Associations: American Diabetes Association's Scientific Sessions, June 22-26, 2018, Orlando, US, World Congress on Prevention of Diabetes and its Complications, July 15-18, 2018, Edinburgh, UK, Diabetes Complications Conference & Grand Rounds (DCOM 2018), July 24-25, 2018, Sarawak, Malaysia, World Congress on Diabetes and Endocrinology, August 22-23, 2018, Rome, Italy, Diabetic Foot Global Conference, October 11-13, 2018, Texas , US,  Immunology of Diabetes Society Congress, October 25-29, 2018, London, UK,  US National Conference on Prevention of Diabetes, November 16-18, 2018, Atlanta, US,  International Diabetes Federation Western Pacific Region Congress, November 22-25, 2018,  World Congress on Clinical Trials in Diabetes, December 3-4, 2018, Vienna, Austria. European Association for the Study of Diabetes, Italy, International Diabetes Federation, Belgium, Joslin Diabetes Center, US, Diabetes UK, London, Diabetes Hands Foundation, California, US, American Diabetes Association, Virginia, US, Insulin for Life USA, Florida, US.

 

Session 21: Recent Advances in Nanotechnology for Diabetes

Nanotechnology in diabetes investigate has encouraged the advancement of novel glucose estimation and insulin conveyance modalities which hold the possibility to drastically enhance personal satisfaction for diabetics. Ongoing advancement in the field of diabetes look into at its interface with nanotechnology is our core interest. In particular, glucose sensors with nanoscale components including metal nanoparticles and carbon nanostructures. The addition of nanoscale components commonly increases glucose sensor sensitivity, temporal response, and can lead to sensors which facilitate continuous in vivo glucose monitoring. Nanoscale survey approaches 'closed-loop' insulin delivery strategies which automatically release insulin in response to fluctuating blood glucose levels (BGLs).

Related conferences and Associations: American Diabetes Association's Scientific Sessions, June 22-26, 2018, Orlando, US, World Congress on Prevention of Diabetes and its Complications, July 15-18, 2018, Edinburgh, UK, Diabetes Complications Conference & Grand Rounds (DCOM 2018), July 24-25, 2018, Sarawak, Malaysia, World Congress on Diabetes and Endocrinology, August 22-23, 2018, Rome, Italy, Diabetic Foot Global Conference, October 11-13, 2018, Texas , US,  Immunology of Diabetes Society Congress, October 25-29, 2018, London, UK,  US National Conference on Prevention of Diabetes, November 16-18, 2018, Atlanta, US,  International Diabetes Federation Western Pacific Region Congress, November 22-25, 2018,  World Congress on Clinical Trials in Diabetes, December 3-4, 2018, Vienna, Austria. European Association for the Study of Diabetes, Italy, International Diabetes Federation, Belgium, Joslin Diabetes Center, US, Diabetes UK, London, Diabetes Hands Foundation, California, US, American Diabetes Association, Virginia, US, Insulin for Life USA, Florida, US.

 

 

Diabetes Research is disturbing expansion in the ordinariness of different hormone-related remedial conditions, for example, hypogonadism, diabetes, hyperthyroidism, and hypothyroidism, the general market for endocrinology drugs advance has been seeing a puzzling upsurge in its general size and valuation. Since the occasion rate of diabetes is astoundingly high completed the world, fuelled by an appalling eating routine and the diminishing relationship of customers in physical exercises, the general market is likely going to stay to encounter a high-paced ascend in the years to come.

During last decade there is a tremendous increase in the number of diabetic population. Different types of drugs are available in the market but there is no available treatment can cure diabetes totally. Diabetes therapeutics are drugs used by diabetic patients to conserve the blood glucose levels in the body. The market growth is boosted by the support from the government and growth in awareness among people about self-management of diabetes. However, side effects of diabetic drugs on patients and stringent approval process for these drugs hinder this growth. The global diabetes care devices & drugs market are mainly driven by the increasing incidence & prevalence of diabetes, technological advancements, rising obesity rate, and increasingly sedentary lifestyle & improper diet. Increasing government support will help to boost the market in coming future. In certain conditions such as cost issues, strict regulatory and long approval time decline the growth of the market.

Why Dubai?

Dubai is the largest and most populous city in the United Arab Emirates (UAE). On the southeast coast of the Persian Gulf, it is the capital of the Emirate of Dubai, one of the seven emirates that make up the country. Dubai is a global city and business hub of the Middle East. It is also a major transport hub for passengers and cargo. Oil revenue helped accelerate the early development of the city, but its reserves are limited and production levels are low: today, less than 5% of the emirate's revenue comes from oil. Dubai's economy now relies on revenues from tourism, aviation, real estate, and financial services. Dubai has attracted world attention through large construction projects and sports events, in particular, the world's tallest building, the Burj Khalifa. Dubai has been criticised for human rights violations against the city's largely South Asian and Filipino workforce. As of 2012, Dubai was the most expensive city in the Middle East.  

Men 'develop diabetes more easily'

Researchers may have discovered why men may be more likely to develop type 2 diabetes than women, BBC News has reported. The broadcaster said that a new study has found men are biologically more susceptible and need to gain far less weight than women to develop the condition. In the study, Scottish researchers examined the records of 95,057 men and women with type 2 diabetes (a condition caused by too much glucose, a type of sugar, in the blood), looking at their ages and body mass index (BMI) scores at the time of diagnosis. A clear trend was found in their results, with men developing type 2 diabetes at a lower BMI than women of a similar age. The researchers have speculated on why this may be the case, and have offered theories that men may be less sensitive to insulin than women or that males tend to store fat around their organs rather than under the skin as women do. However, the proposed reasons are only theories and cannot be confirmed by this study, which examined a limited range of factors at a single point in time.

Figure 1: Prevalence of diabetes, among persons aged 18 and over, by age and sex, 2014–15

 

Overall, the observation that men seem to develop type 2 diabetes at a lower BMI than women of the same age is worthy of further exploration. As Dr. Victoria King, Head of Research at Diabetes UK, told the BBC: "It is worrying that men develop type 2 diabetes at a higher rate than their female counterparts.

Market Growth of Diabetes in the Last and Upcoming Years in Dubai

In Europe, the market is driven by a sudden rise in the number of people affected with diabetes and with high investments in R & D. Also, with an increasing awareness among the patients, there is quite a hike in the demand for diabetes care devices. Due to the reimbursement and patent expiry issues, the market growth in Europe is constrained. Governing rules on healthcare reimbursement keep changing frequently, with government payers sometimes changing on a day-to-day basis. This overall makes the situation complex as it is very difficult for practices to understand payer rules, keep up with changes to those rules. With such problems prevalent, there is a high risk of losing customers due to which there could be a significant drop in the market growth in Europe.

The European Diabetes Care Devices Market has been evaluated at USD 4.616 billion out of 2015 and is anticipated to achieve USD 5.999 billion by 2020, at a CAGR of 5.38% amid the figure time frame from 2015 to 2020. Diabetes is a gathering of the metabolic issue, a perpetual condition which is related with strangely abnormal state of sugar (glucose) in the blood. Europe at present witnesses 59.8 million individuals influenced with Diabetes which will achieve 71.1 million by 2040.

Geographically, Europe is divided into Germany, UK, France, Italy and Rest of Europe. It is the second largest market share contributor in the world following North America, with a number of market revenue creating companies based in Europe. With such projects already in progress, there is a lot of scope for market growth in this region. Government policies and subsidies play a vital role in the growth of the market. With the increasing policies, there is a significant rise in the investments of the devices by the companies, due to which there is a commendable growth in the European Diabetes Care Devices market.

Market Growth of Diabetes in the Asia Pacific

Due to Growing global prevalence of diabetes and the increasing incidence rates of lifestyle induced disorders such as obesity are one of the reasons to drive market growth over the next six years. By International Diabetes Federation, the estimation generated that the global prevalence of diabetes is expected to increase 366 million in 2011 to 552 million by 2030. Such type of rapid growth in prevalence is expected to have a high impact on market growth over the forecast period. Three major companies including Novo Nordisk, Eli Lilly, and Sanofi Aventis dominated the Asia Pacific Insulin market. Therefore all these companies try an attempt to preserve market share engage in extensive R&D initiatives to develop novel insulin products with relatively higher efficacies for their growth. The Asia Pacific is one of the fastest growing regions for the market due to the presence of a huge patient population, continuously developing economies and increasing need for the better treatment. Diabetes is the metabolic sickness where there is an increment in glucose level. The increment in glucose level is expected less or no insulin emission by the body. Diabetes is presently a day turning into a noteworthy issue in numerous nations. Expanding predominance of diabetes, government activities are the significant driving component for the market. Presentation of the diabetic pen has to assist the diabetic patient by administering insulin at their home itself. The Asia Pacific is the quickest developing business sector for the diabetic pen.

Figure 2: Insulin Pen Cap Market Share(%) by region

The market for Asian diabetes devices which is having products like lancets, insulin pumps, and glucose monitoring devices, is growing at a rate of over 8% annually. The diabetes drug market is expected to double by 2030 with the rising number of diabetics. Diabetes drugs include insulin, but also medications that help with other functions such as breaking down sugar and decreasing the liver’s sugar production. According to the 2016 report published by Asian diabetes drug market was about $8 billion of the $25 billion global diabetes drug market.

These are groups of researchers working, meeting, sharing ideas and striving for answers together. The current Study Groups are:

·         Artificial Insulin Delivery System (AIDPIT)

·         Diabetes Education Study Group (DESG)

·         Diabetic Pregnancy Study Group (DPSG)

·         Diabetes Neuropathy Study Group (NEURODIAB)

·         EASD Eye Complication Study Group (EASDEC)

·         European Diabetic Nephropathy Study Group (EDNSG)

·         EASD Islet Study Group

·         European Diabetes Epidemiology Group (EDEG)

·         Diabetes and Nutrition Study Group (DNSG)

·         Psychosocial Aspects of Diabetes (PSAD)

·         Diabetic Foot Study Group (DFSG)

·         EASD Study Group on Primary Care Research in Diabetology (PCD)

·         Diabetes Economic and Care Delivery (DECADE)

·         Genetics of Diabetes Study Group (SGGD)

·         Diabetes and Cardiovascular Disease Study Group (D&CVD).

 

  • Recent Advancement in Diabetes
  • Diabetes and Nutrition
  • Diabetes and Cancer
  • Genetic Diabetes
  • Biomarkers for Diabetes
  • Diabetes and Obesity
  • Diabetic Meal Plan
  • Diabetes and Immunology
  • Consequences of Diabetes in Human
  • Stem Cell Therapy for Diabetes
  • Cellular and Molecular Endocrinology
  • Diabetes in Healthcare
  • Case Studies and New Research Advances in Diabetes
  • Diabetic Retinopathy
  • Diabetes and Treatment
  • Neurologic Problems and Diabetes
  • Hypertension and Diabetes
  • Endocrine Complications of Diabetes
  • Diabetes and Cardiovascular Diseases
  • Pediatric diabetes
  • Recent Advances in Nanotechnology for Diabetes

A PHP Error was encountered

Severity: Warning

Message: Unknown: Failed to write session data (user). Please verify that the current setting of session.save_path is correct (/var/www/meetingsint/application/ci_session)

Filename: Unknown

Line Number: 0

Backtrace: